Myriad Genetics, Inc. (17) | Human Resources (10)
Browse by Subcategory
Recent Contracts
-
Separation and
(Filed With SEC on February 9, 2022)
-
Performance-Based Restricted Stock Unit Agreement between the Registrant and Paul J. Diaz dated October 8, 2020
(Filed With SEC on November 9, 2020)
-
Executive Employment Agreement between the Registrant and Paul J. Diaz dated July 24, 2020
(Filed With SEC on November 9, 2020)
-
Form of Severance and Change in Control Agreement
(Filed With SEC on October 15, 2020)
-
Separation and Consulting Agreement, dated May 6, 2020, by and between Myriad Genetics, Inc. and Mark C. Capone
(Filed With SEC on May 12, 2020)
-
Form of Executive Retention Agreement
(Filed With SEC on February 7, 2020)
-
Performance-Based Non-Qualified Stock Option Agreement between the Registrant and Paul J. Diaz dated August 13, 2020
(Filed With SEC on November 9, 2020)
-
Form of Separation and Release
(Filed With SEC on November 9, 2020)
-
2017 Employee, Director and Consultant Equity Incentive Plan, as amended as of October 9, 2020
(Filed With SEC on October 15, 2020)
-
Myriad Genetics, Inc. 2017 Employee, Director and Consultant Equity Incentive Plan, as amended
(Filed With SEC on December 6, 2019)